Development and Qualification of an Antigen Integrity Assay for a IPlasmodium falciparum/I Malaria T...
Development and Qualification of an Antigen Integrity Assay for a IPlasmodium falciparum/I Malaria Transmission Blocking Vaccine Candidate, Pfs230
About this item
Full title
Author / Creator
Publisher
MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
MDPI AG
Subjects
More information
Scope and Contents
Contents
During development of a subunit vaccine, monitoring integrity of the recombinant protein for process development and quality control is critical. Pfs230 is a leading malaria transmission blocking vaccine candidate and the first to reach a Phase 2 clinical trial. The Pfs230 protein is expressed on the surface of gametes, and plays an important role...
Alternative Titles
Full title
Development and Qualification of an Antigen Integrity Assay for a IPlasmodium falciparum/I Malaria Transmission Blocking Vaccine Candidate, Pfs230
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A746716806
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A746716806
Other Identifiers
ISSN
2076-393X
E-ISSN
2076-393X
DOI
10.3390/vaccines10101628
